Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook based on expected improvements in the fundamentals of the business [5][53]. Core Insights - The company is positioned as a leading player in the dairy industry, with a comprehensive business model covering the entire dairy supply chain, including breeding, feed, and dairy farming [10][26]. - The report anticipates a recovery in raw milk prices, which have been at historical lows, and expects this to benefit the company significantly due to its scale and operational efficiencies [22][36]. - The company has a strong relationship with its major customer, Yili, which accounts for over 90% of its raw milk sales, providing stability in revenue [18][16]. Summary by Sections Market Performance - The company's closing price is HKD 3.45, with a market capitalization of approximately HKD 13.43 billion [3]. Financial Forecasts and Valuation - Revenue projections for 2025-2027 are estimated at RMB 20.99 billion, RMB 22.98 billion, and RMB 24.44 billion, respectively, with year-on-year growth rates of 4.49%, 9.42%, and 6.35% [6][51]. - The report forecasts a turnaround in net profit, with expected figures of RMB -1.05 billion, RMB 2.04 billion, and RMB 2.99 billion for the years 2025-2027 [6][51]. Business Overview - The company is the largest raw milk supplier globally, with a robust operational structure that includes 100 large-scale farms and a focus on high-quality dairy products [14][26]. - The company has been expanding its product offerings, including specialty milk products, which command higher prices than standard raw milk [31][34]. Industry Dynamics - The report highlights an expected increase in demand for dairy products in China, driven by rising health awareness and consumption patterns [25][22]. - The meat and dairy sectors are anticipated to experience a positive correlation, with rising beef prices benefiting the company's profitability from the sale of culled dairy cows [36][41]. Competitive Positioning - The company benefits from significant scale advantages, technological capabilities, and a strong brand presence in the dairy market, positioning it well for future growth [10][26].

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [2][7][8]. Core Insights - The company has demonstrated operational efficiency improvements and is positioned to benefit from a potential industry cycle reversal [2][4]. - In H1 2025, the company achieved revenue of 10.284 billion yuan, a year-on-year increase of 2.3%, and a net profit attributable to shareholders of -297 million yuan, reflecting a reduction in losses by 34 million yuan [4]. - The company is the largest upstream provider of dairy products and services in China, maintaining operational resilience amid significant industry pressures [7]. Financial Performance Summary - Revenue from raw milk business reached 7.896 billion yuan in H1 2025, up 7.9% year-on-year, driven by improved productivity and optimized herd structure [4]. - The average price of raw milk was 3.87 yuan per kilogram, down 7% year-on-year, while the average feed cost for high-quality fresh milk was 1.91 yuan per kilogram, down 12% [4]. - The company’s cash EBITDA for H1 2025 was 2.811 billion yuan, reflecting a year-on-year increase of 7.1% [5]. Future Projections - The company is projected to achieve revenues of 20.953 billion yuan, 22.331 billion yuan, and 23.922 billion yuan for the years 2025, 2026, and 2027, respectively, with growth rates of 4% and 7% [6][7]. - Net profit attributable to shareholders is expected to be 340 million yuan, 1.256 billion yuan, and 2.153 billion yuan for the same years, with significant growth rates of 149%, 269%, and 71% [6][7]. - The report anticipates an improvement in return on equity (ROE) from -6% in 2024 to 14% by 2027 [8].